budesonide + formoterol + prednisolone

This is a combination drug consisting of three active pharmaceutical ingredients: - Budesonide, an inhaled corticosteroid that reduces inflammation in the airways. - Formoterol, a long-acting beta2-adrenergic agonist (LABA) that acts as a bronchodilator to relax airway smooth muscle and improve airflow. - Prednisolone, an oral corticosteroid with potent anti-inflammatory and immunosuppressive properties. The combination of budesonide and formoterol is commonly used as an inhaled therapy for asthma and chronic obstructive pulmonary disease (COPD), while prednisolone is typically administered orally for acute exacerbations. This triple regimen may be used in certain clinical scenarios such as acute COPD exacerbations where both systemic and inhaled anti-inflammatory effects are desired alongside bronchodilation. The mechanism of action involves reducing airway inflammation (budesonide, prednisolone) and promoting bronchodilation (formoterol). Studies have compared high-dose budesonide/formoterol to oral prednisolone plus formoterol for acute COPD exacerbations, finding similar efficacy between regimens[1][4].